reserv l-t direct maintain
market perform rate think recent under-perform wake
overdon data indic retail rx declin april improv slightli may
april trend indic much less impact believ result like
similar broader market
share trade adj ep estimate think current valuat
reflect overli pessimist outlook believ multipl adj ep estimate
appropri impli pt although pt impli upsid
maintain market perform rate continu reserv regard
l-t strategi believ pressur share larg attribut declin
same-stor script growth due lockdown declin script across
broader market april y/i per iqvia data report adj script growth
y/i april given share number characterist includ
nationwid footprint optim store locat believ script growth
like consist broader market would also argu script
growth may stabl due higher exposur medicar part
also note script trend first week may indic slight improv
term y/i growth q/q growth retail script growth y/i week end
may compar april expect improv continu patient
refil script pull forward march doctor offic reopen
reserv compani report cowen compani
pleas see page report import disclosur
market perform rate think compani weakli posit
transit toward value-bas care rel peer other pharma
suppli chain manag care industri consolid integr medic
pharmaci data pursu partnership strategi retail-centr
also think ownership acquisit aet rather partnership open
health hub necessari realiz benefit cost trend improv without
see potenti margin distribut channel greater risk
disrupt furthermor manag consist meet exceed adj ep
estim fare well base oper metric think indic
challeng macro environ
y/i top-lin growth
margin pressur continu
share repo
y/i top-lin growth mid-singl
digit due moder
expect impact
lower expect reimburs
faster expect realiz cost
share repo greater
flat top-lin growth due
wors expect impact
greater expect margin pressur
slower expect realiz cost
walgreen oper largest drugstor chain compani sell product
servic retail drugstor mail telephon on-line
channel within store walgreen sell prescript non-prescript drug
well gener merchandis includ household item conveni fresh food
person care beauti care photo finish candi primarili within retail locat
walgreen oper take clinic walgreen also oper specialti infus
respiratori servic mail servic
lower adj ep estimate reflect updat
assumpt base management comment rx data april data
retail usa expect compstore comp compris pharmaci compstore
retail base assumpt compstore pharmaci retail
remain neg remaind quarter although lesser extent
seen last week march assum mid-singl digit script growth march
mid-singl digit declin april low-singl digit declin may also expect adj
sg wors previous expect given relat cost
realloc resourc away transform program result adj
op profit y/i
retail pharmaci expect even signific impact segment
retail usa given boot lever toward beauti come
greater pressur due decreas discretionari spend temporari ban
purchas nonessenti good estimate y/i declin revenue y/i
declin adj op profit particularli margin come greater pressur due
lower sale beauti carri higher margin
lower adj ep est
respect also lower revenue est
respect note lower revenue estimate
consensu well revenue estimate
consensu lower pt
base revis dcf analysi impli share trade almost
adj ep estimate
million except per-shar data
cowen compani
model assumptionstermin growth tax depreci chang work terminal- capit valuefre pv npv free npv futur excess valu total number valu per year end august cowen
million except per-shar data
compani report cowen compani
fifo cost fifo gross fifo gross chang lifo lifo gross lifo gross equiti earn ab- adjust equiti earn adjust oper adjust oper interest expens pre-tax pre-tax tax report incom tax incom tax tax earn equiti method net earn non-controlling adjust net total net averag dilut adjust chang gross gross oper year end august cowen
million except per-shar data
compani report cowen compani
fifo cost fifo gross fifo gross chang lifo lifo gross lifo gross equiti earn ab- adjust equiti earn adjust oper adjust oper interest expens pre-tax pre-tax tax report incom tax incom tax tax earn equiti method net earn non-controlling adjust net total net averag dilut adjust chang gross gross oper cowen
million
compani report cowen compani
asset cash account receiv current current properti intang non-curr total current liabil short-term trade account accru expens incom current long-term defer incom non-curr stockhold equiti common paid-in employe stock loan receivable- retain accumul comprehens treasuri non-controlling total stockhold total liabil stockhold short-term liquid ratio current sale purchas acct ratio inventori structur long-term solvenc ratio total debt total interest ratio return invest capit averag total asset averag stockhold equiti year end august cowen
million
compani report cowen compani
income/ loss flow oper activ depreci gain previous held equiti interest- share base compens unreal gain fair valu adjustments- defer incom invest impair chang oper asset liabil receiv current non-curr account accru expens incom non-curr net cash oper acquisit properti acquisit issuanc common purchas treasuri dividend proceeds/ purchas secur proceeds/ repay debt net increase/ decreas cash equival begin cash equival end cowen summari oper capit owner financ non-recur exclud non-recur itemsfor year end august cowen
million
compani report cowen compani
flow oper activ net adjust reconcil net earn net cash depreci loss allianc boot call option- sale defer incom stock compens incom tax save employe stock plans- chang oper asset liabil account receiv current trade account accru expens incom non-curr asset net cash provid oper flow invest activitiesaddit properti proce sale leaseback transactions- purchas short-term invest held proce short-term invest held purchas short-term invest avail sale- proce sale short-term invest avail sale- return invest restrict cash- proce sale busi intang asset acquisit net cash payment proce sale invest invest allianc net cash use invest flow financ activitiesnet payment short-term payment long-term proce financ leases- issuanc long-term stock proce relat employe stock dividend net cash provid use financ effect exchang rate chang cash cash chang equivalentsnet decreas cash cash cash equival begin cash equival end year end august cowen
use five-year discount cash flow analysi primari valuat method
deriv price target gener assum discount rate may appli
appropri adjust depend compani and/or industri specif factor also
assum termin growth rate depend long-term view specif
sub-industri coverag note discount rate assumpt could view
conserv rel actual weight averag cost capit view
assumpt reason long run lower discount rate assumpt
increas termin growth rate assumpt would lead higher estim valu
per share secondari measur look forward price-to-earnings multipl ev/sal ratio
impli dcf analysi compar histor averag
see number risk associ drug retail space industri highli
competit retail drugstor chain independ pharmaci mail-ord provid
well retail includ groceri store mass merchant warehous club on-line
store compet space could pressur front-end sale margin
current wave drug patent expir posit impact profit
deriv gener expect taper significantli next sever year
specialti provid signific tailwind part believ
could concern around sustain high growth area
believ impact ppaca expect increas volum could subdu
depend implement execut
number company-specif risk associ pt includ loss
share disrupt entiti wors expect reimburs pressur better
expect gener procur wbad meaning acquisit
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
cowen compani llc affili make market stock secur
cowen compani llc compens research analyst activ servic intend benefit firm investor client individu compens determin research
analyst includ author report base varieti factor includ overal profit firm total revenu deriv sourc includ
revenu invest bank sale trade princip trade revenu cowen compani llc compens research analyst base specif invest
bank transact specif sale trade princip trade revenu
statement find conclus view opinion contain express herein necessarili iqvia affili subsidiari entiti analysi
independ arriv cowen compani basi data inform
research report simultan avail client client websit research report client research report dissemin e-mail
made avail third-parti aggreg cowen compani llc respons redistribut research third parti aggreg select research report
avail print form addit electron form publish research report obtain firm client websit http //cowenlibrari bluematrix com/client/
inform opinion estim forecast date report subject chang without prior notif seek updat research appropri
variou regul may prevent us research report publish irregular interv appropri analyst judgement
inform subject secur may obtain offic research report publish sole inform purpos constru offer
sell solicit offer buy secur state offer solicit would illeg disclosur relat cowen compani llc
